Available to sourceHuman Prescription DrugGastrointestinal

PRISMASOL

Active ingredients · Lactic Acid, Magnesium Chloride, Sodium Bicarbonate, Sodium Chloride

5.4 g/L / 2.44 g/L / 3.09 g/L / 6.46 g/L · Injection

By Vantive US Healthcare LLC

NDC: 24571-113
Route: Intravenous
Therapeutic class: Acidifying Activity [MoA], Calculi Dissolution Agent , Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.